Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/29/2003US6555134 Synergistic mixtures of garlic and lycopene for preventing LDL oxidation
04/29/2003US6555133 Oral dosage
04/29/2003US6555132 Soft gelatin capsule manufacture
04/29/2003US6555131 Solid solution of a copolymer of ethyl acrylate and methyl methacrylate containing about 5% trimethylammonium ethyl methacrylate chloride as the sole (meth)acrylate copolymer and an ester of a weak acid as plasticizer
04/29/2003US6555129 Transdermal therapeutic system (TTS) containing oxybutynin
04/29/2003US6555127 Multi-spike release formulation for oral drug delivery
04/29/2003US6555126 Method for treating, controlling, and preventing Diabetes Mellitus
04/29/2003US6555124 Reversibly increasing the permeability to active agents of epithelial cells; applied orally, sublingually, buccally, rectally, pulmonarily or nasally or through the mucosa of the eye.
04/29/2003US6555104 Administering biocompatible polymer
04/29/2003CA2227513C New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them
04/29/2003CA2225797C Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
04/29/2003CA2219348C Solvent detergent emulsions having antiviral activity
04/29/2003CA2181172C Storage-stable prostaglandin compositions
04/29/2003CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
04/29/2003CA2156505C Compositions and methods for promoting hair growth
04/29/2003CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors
04/29/2003CA2123160C Controlled release formulation
04/29/2003CA2103571C Method of treating pulmonary inflammation
04/29/2003CA2078028C A tramadol n-oxide material, enantiomers and compositions thereof, and their use
04/25/2003CA2426925A1 Water-soluble liquid internal medicine
04/25/2003CA2409910A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
04/25/2003CA2409552A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
04/25/2003CA2407217A1 Cosmetic use of dhea derivatives
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003034067A1 Modulation of tor
04/24/2003WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma
04/24/2003WO2003033808A2 Composition and method for treating diabetes
04/24/2003WO2003033703A2 Human gtp-activator protein for rab-like gtpase
04/24/2003WO2003033692A2 Use of the adenoviral e2 late promoter
04/24/2003WO2003033681A2 Composition comprising a lactobacillus pentosus strain and uses thereof
04/24/2003WO2003033678A2 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
04/24/2003WO2003033657A2 Antisense antiviral agent and method for treating ssrna viral infection
04/24/2003WO2003033632A1 Cholesterol lowering structured lipids with omega 6 pufa
04/24/2003WO2003033524A2 Peptidyl ketones as inhibitors of dpiv
04/24/2003WO2003033518A1 Steroidal compounds for inhibiting steroid sulphatase
04/24/2003WO2003033511A1 Pt(iv) complex with antineoplastic activity: trans-[ptcl2(oh)2 (dimethylamine) (isopropylamine)] used as an antitumour agent
04/24/2003WO2003033508A1 Pharmaceutically acceptable alendronate salts in amorphous form
04/24/2003WO2003033506A1 Aminoborane acid derivative and proteasome inhibitory drug containing the same
04/24/2003WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003WO2003033501A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
04/24/2003WO2003033497A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity
04/24/2003WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors
04/24/2003WO2003033495A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
04/24/2003WO2003033494A1 Benzimidazole derivative
04/24/2003WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ
04/24/2003WO2003033491A1 Medicinal composition for prevention or alleviation of side effect of antitumor and medicinal antitumor composition
04/24/2003WO2003033489A1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same
04/24/2003WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
04/24/2003WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
04/24/2003WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
04/24/2003WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003WO2003033471A1 Novel pyridone derivative and remedial agent for circulatory disease containing the same
04/24/2003WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
04/24/2003WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
04/24/2003WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors
04/24/2003WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS
04/24/2003WO2003033455A1 Oligoamine compounds and derivatives thereof for cancer therapy
04/24/2003WO2003033453A1 Dicarboxylic acid derivatives, their preparation and therapeutical use
04/24/2003WO2003033445A1 Stabilized compositions of aqueous reduced coenzyme q solution
04/24/2003WO2003033048A2 Drug delivery system for conscious sedation
04/24/2003WO2003033031A1 Dosage form, device and methods of treatment
04/24/2003WO2003033029A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications
04/24/2003WO2003033027A2 Dendrimers for use in targeted delivery
04/24/2003WO2003033026A1 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
04/24/2003WO2003033025A2 Cyclodextrin complexes
04/24/2003WO2003033024A1 Cell proliferation inhibitor
04/24/2003WO2003033023A1 Drugs ameliorating hypo-hdl cholesterolemia
04/24/2003WO2003033022A1 Use of oxaziridine derivatives and precursors in the treatment of dermatoses
04/24/2003WO2003033020A1 Composition and method to treat post-illness wasting phenomenon
04/24/2003WO2003033015A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY
04/24/2003WO2003033014A2 Novel use of pulmonary surfactant
04/24/2003WO2003033005A1 Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same
04/24/2003WO2003033004A1 Agents for treating inflammatory bowel diseases
04/24/2003WO2003033003A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator
04/24/2003WO2003033002A1 Intracellular calcium concentration increase inhibitors
04/24/2003WO2003033001A1 Combinations comprising cox-2 inhibitors and aspirin
04/24/2003WO2003033000A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma
04/24/2003WO2003032999A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003WO2003032998A1 Sustained-release fine particle and process for producing the same
04/24/2003WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
04/24/2003WO2003032996A1 Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists
04/24/2003WO2003032995A1 Rosuvastatin in pre demented states
04/24/2003WO2003032994A2 Novel tri-substituted pyrimidines, method for production and use thereof as medicament
04/24/2003WO2003032993A1 Use of phosphorodiesterase iv inhibitors
04/24/2003WO2003032992A1 Use of inhibitors of the y2 receptor of neuropeptide y in the treatment of alcoholism
04/24/2003WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists
04/24/2003WO2003032990A2 Polymer conjugates of opioid antagonists
04/24/2003WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/24/2003WO2003032988A1 Pharmaceutical composition
04/24/2003WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032985A2 Concomitant oral and topical administration of anti - infective agents
04/24/2003WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
04/24/2003WO2003032983A1 Transdermal migraine therapy
1 ... 5488 5489 5490 5491 5492 5493 5494 5495 5496 5497 5498 5499 5500 5501 5502 5503 5504 5505 5506 5507 5508 ... 7860